Skip to content

Construction and Evaluation of Evidence Based Respiratory Muscle Training Programs for COPD Patients with Different Severity Levels

Construction and Evaluation of Evidence Based Respiratory Muscle Training Programs for COPD Patients with Different Severity Levels

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110019
Enrollment
Unknown
Registered
2025-09-28
Start date
2023-03-13
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease

Interventions

Interventional group:Develop personalized respiratory function training plans for individual patients based on evidence-based medicine comprehensive evaluation 32/10000 32/10000, Develop personaliz
Control group:Execute according to routine respiratory function training

Sponsors

The 910th Hospital of the Joint Service Support Force of the Chinese People's Liberation Army
Lead Sponsor

Eligibility

Sex/Gender
All
Age
41 Years to 80 Years

Inclusion criteria

Inclusion criteria: Complete clinical data; All patients met the diagnostic criteria for COPD and were diagnosed through imaging and pulmonary function tests; Age range of 40-80 years old; Vital signs are stable, consciousness is clear, there are no cognitive impairments, and the correct operation methods for the treatment used in this study can be mastered; No respiratory infectious diseases.

Exclusion criteria

Exclusion criteria: Patients with serious organic diseases such as heart, liver, kidney, systemic diseases, tumors, and other life-threatening conditions; Patients who refuse to participate in this study; Patients with mental illnesses who cannot follow instructions to complete relevant examinations; Other airflow restriction diseases with known causes or characteristic pathological manifestations (such as asthma, bronchiectasis, tuberculosis, lung cancer, idiopathic pulmonary fibrosis, diffuse panbronchiolitis, etc.).

Design outcomes

Primary

MeasureTime frame
Pulmonary function indicators (including forced expiratory volume in 1 second, forced vital capacity, ratio of FEV1 to FVC, and peak expiratory flow);Exercise tolerance;

Secondary

MeasureTime frame
Arterial blood gas analysis (including partial pressure of oxygen, partial pressure of carbon dioxide, and oxygen saturation);Dyspnea score;Quality of life score;Respiratory muscle strength;

Countries

China

Contacts

Public ContactHuang Zhongjie

The 910th Hospital of the Joint Service Support Force of the Chinese People's Liberation Army

h_zhongjie1982@163.com+86 180 0505 4180

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026